| 國立成功大學 |
2022 |
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
|
Zhu, A.X.;Dayyani, F.;Yen, C.-J.;Ren, Z.;Bai, Y.;Meng, Z.;Pan, H.;Dillon, P.;Mhatre, S.K.;Gaillard, V.E.;Hernandez, S.;Kelley, R.K.;Sangro, B. |
| 國立成功大學 |
2022 |
NEIL3 promotes hepatoma epithelial–mesenchymal transition by activating the BRAF/MEK/ERK/TWIST signaling pathway
|
Lai, H.-H.;Hung, L.-Y.;Yen, C.-J.;Hung, Hung H.-C.;Chen, R.-Y.;Ku, Y.-C.;Lo, H.-T.;Tsai, H.-W.;Lee, Y.-P.;Yang, T.-H.;Chen, Y.-Y.;Huang, Y.-S.;Huang, W. |
| 臺大學術典藏 |
2021-11-17T07:23:43Z |
Functional assessment of chronic illness therapy-the fatigue scale exhibits stronger associations with clinical parameters in chronic dialysis patients compared to other fatigue-assessing instruments
|
Chao C.-T.; Huang J.-W.; Chiang C.-K.; Yen C.-J.; Hung Y.-C.; Hsu S.-H.; CHI-YUAN SHIH; Lai C.-F.; Chan D.-C.D.; Hung K.-Y.; Chu T.-S.; Huang S.-J.; COGENT (COhort of GEriatric Nephrology in NTUH) study group |
| 臺大學術典藏 |
2021-08-31T06:42:27Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen Y.-C.; Li C.-P.; Yen C.-J.; Hsu C.; Lin Y.-L.; Lin Z.-Z.; Chen L.-T.; Su W.-C.; Chao Y.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:42:22Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; Yeh K.-H.; Lu Y.-S.; ANN-LII CHENG; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:38Z |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa G.K.; Yen C.-J.; Hsu C.-H.; O��Donoghue J.; Beylergil V.; Ruan S.; Pandit-Taskar N.; Gansukh B.; Lyashchenko S.K.; Ma J.; Wan P.; Shao Y.-Y.; Lin Z.-Z.; Frenette C.; O��Neil B.; Schwartz L.; Smith-Jones P.M.; Ohtomo T.; Tanaka T.; Morikawa H.; Maki Y.; Ohishi N.; Chen Y.-C.; Agajanov T.; Boisserie F.; Di Laurenzio L.; Lee R.; Larson S.M.; ANN-LII CHENG; Carrasquilo J.A. |
| 臺大學術典藏 |
2021-08-31T06:29:36Z |
mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib
|
Meyer T.; Palmer D.H.; ANN-LII CHENG; Hocke J.; Loemb? A.-B.; Yen C.-J. |
| 臺大學術典藏 |
2021-08-31T06:29:28Z |
A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma
|
Yen C.-J.; Kim T.-Y.; Feng Y.-H.; Chao Y.; Lin D.-Y.; Ryoo B.-Y.; Huang D.C.-L.; Schnell D.; Hocke J.; Loemb? A.-B.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:21Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:18Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen L.-T.; Martinelli E.; ANN-LII CHENG; Pentheroudakis G.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Hsu C.; Shen Y.-C.; Tabernero J.; Yen Y.; Hsu C.-H.; Yoshino T.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-08-31T06:29:18Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de Bono J.; Lin C.-C.; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; Lee J.-H.; Hsu C.-H.; Yang J.C.-H.; Shiah H.-S.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Strelkowa N.; Huang D.C.-L.; Bogenrieder T.; Twelves C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:13Z |
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
|
Ryoo B.-Y.; ANN-LII CHENG; Ren Z.; Kim T.-Y.; Pan H.; Rau K.-M.; Choi H.J.; Park J.-W.; Kim J.H.; Yen C.J.; Lim H.Y.; Zhou D.; Straub J.; Scheele J.; Berghoff K.; Qin S. |
| 臺大學術典藏 |
2021-08-24T05:21:51Z |
Lean Body Mass Predicts Long-Term Survival in Chinese Patients on Peritoneal Dialysis
|
Huang J.-W.; Lien Y.-C.; Wu H.-Y.; Yen C.-J.; Pan C.-C.; Hung T.-W.; CHI-TING SU; Chiang C.-K.; Cheng H.-T.; Hung K.-Y. |
| 臺大學術典藏 |
2021-08-20T08:19:53Z |
Citrobacter peritoneal dialysis peritonitis: Rare occurrence with poor outcomes
|
CHIA-TER CHAO; Lee S.-Y.; Yang W.-S.; Chen H.-W.; Fang C.-C.; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2021-08-20T08:19:53Z |
Peritoneal dialysis peritonitis by anaerobic pathogens: A retrospective case series
|
CHIA-TER CHAO; Lee S.-Y.; Yang W.-S.; Chen H.-W.; Fang C.-C.; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2021-08-20T08:19:52Z |
A rare and under-recognized pathogen in peritoneal dialysis peritonitis: Corynebacterium jeikeium
|
CHIA-TER CHAO; Huang J.W.; Yen C.J. |
| 臺大學術典藏 |
2021-08-20T08:19:50Z |
Serum vitamin D levels are positively associated with varicella zoster immunity in chronic dialysis patients
|
CHIA-TER CHAO; Lee S.-Y.; Yang W.-S.; Yen C.-J.; Chiang C.-K.; Huang J.-W.; Hung K.-Y. |
| 臺大學術典藏 |
2021-08-20T08:19:49Z |
Acinetobacter peritoneal dialysis peritonitis: A changing landscape over time
|
CHIA-TER CHAO; Lee S.-Y.; Yang W.-S.; Chen H.-W.; Fang C.-C.; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2021-08-20T08:19:48Z |
Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses of patients with end-stage renal disease
|
CHIA-TER CHAO; Chen Y.-C.; Chiang C.-K.; Huang J.-W.; Hu F.-C.; Fang C.-C.; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2021-08-20T08:19:47Z |
Intradialytic hypotension and cardiac remodeling: A vicious cycle
|
CHIA-TER CHAO; Huang J.-W.; Yen C.-J. |
| 臺大學術典藏 |
2021-08-20T08:19:47Z |
Viridans streptococci in peritoneal dialysis peritonitis: Clinical courses and long-term outcomes
|
CHIA-TER CHAO; Lee S.-Y.; Yang W.-S.; Chen H.-W.; Fang C.-C.; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2021-08-20T08:19:47Z |
Serum free 1,25-dihydroxy-vitamin D is more closely associated with fibroblast growth factor 23 than other vitamin D forms in chronic dialysis patients
|
CHIA-TER CHAO; Lee S.-Y.; Yen C.-J.; Chiang C.-K.; Huang J.-W.; Hung K.-Y. |
| 臺大學術典藏 |
2021-08-20T08:19:45Z |
Visceral fat area is associated with HbA1c but not dialysate-related glucose load in nondiabetic PD patients
|
Ho L.-C.; Yen C.-J.; CHIA-TER CHAO; Chiang C.-K.; Huang J.-W.; Hung K.-Y. |
| 臺大學術典藏 |
2021-08-20T08:19:44Z |
Functional assessment of chronic illness therapy-the fatigue scale exhibits stronger associations with clinical parameters in chronic dialysis patients compared to other fatigue-assessing instruments
|
CHIA-TER CHAO; Huang J.-W.; Chiang C.-K.; Yen C.-J.; Hung Y.-C.; Hsu S.-H.; Shih C.-Y.; Lai C.-F.; Chan D.-C.D.; Hung K.-Y.; Chu T.-S.; Huang S.-J.; COGENT (COhort of GEriatric Nephrology in NTUH) study group |
| 臺大學術典藏 |
2021-08-20T08:19:44Z |
Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients
|
CHIA-TER CHAO; Chen Y.-C.; Chiang C.-K.; Huang J.-W.; Fang C.-C.; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2021-08-20T08:19:38Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
CHIA-TER CHAO; Huang J.-W.; Chiang C.-K.; Chen Y.-C.; Fang C.-C.; Hu F.-C.; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2021-08-20T04:14:45Z |
Infection associated with double lumen catheterization for temporary haemodialysis: Experience of 168 cases
|
KUAN-YU HUNG; Tsai T.-J.; Yen C.-J.; Yen T.-S. |
| 臺大學術典藏 |
2021-08-20T04:14:44Z |
Continuous ambulatory peritoneal dialysis in the elderly: A seven-year experience
|
KUAN-YU HUNG; Hsu W.-A.; Tsai T.-J.; Yen C.-J.; Hou C.-H.; Yen T.-S. |
| 臺大學術典藏 |
2021-08-20T04:14:43Z |
Effects of Intraperitoneal Antibiotics on Human Peritoneal Mesothelial Cell Growth
|
Yen C.-J.; Tsai T.-J.; Chen H.-S.; Fang C.-C.; Yang C.-C.; Lee P.-H.; Lin R.-H.; Tsai K.-S.; KUAN-YU HUNG; Yen T.-S. |
| 臺大學術典藏 |
2021-08-20T04:14:42Z |
Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: Experience from Taiwan, an endemic area for hepatitis B
|
KUAN-YU HUNG; Lee K.-C.; Yen C.-J.; Wu K.-D.; Tsai T.-J.; Chen W.-Y. |
| 臺大學術典藏 |
2021-08-20T04:14:39Z |
Incidence of exit-site infection with various exchange systems in continuous ambulatory peritoneal dialysis
|
Huang J.-W.; KUAN-YU HUNG; Wu K.-D.; Yen C.-J.; Tsai T.-J.; Hsieh B.-S. |
| 臺大學術典藏 |
2021-08-20T04:14:37Z |
Dipyridamole inhibits PDGF-stimulated human peritoneal mesothelial cell proliferation
|
KUAN-YU HUNG; Chen C.-T.; Yen C.-J.; Lee P.-H.; Tsai T.-J.; Hsieh B.-S. |
| 臺大學術典藏 |
2021-08-20T04:14:37Z |
Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis
|
Huang J.-W.; KUAN-YU HUNG; Yen C.-J.; Wu K.-D.; Tsai T.-J. |
| 臺大學術典藏 |
2021-08-20T04:14:37Z |
Systemic lupus erythematosus and peritoneal dialysis: Outcomes and infectious complications
|
Huang J.-W.; KUAN-YU HUNG; Yen C.-J.; Wu K.-D.; Tsai T.-J. |
| 臺大學術典藏 |
2021-08-20T04:14:34Z |
Adiponectin in peritoneal dialysis patients: A comparison with hemodialysis patients and subjects with normal renal function
|
Huang J.-W.; Yen C.-J.; Chiang H.-W.; KUAN-YU HUNG; Tsai T.-J.; Wu K.-D. |
| 臺大學術典藏 |
2021-08-20T04:14:22Z |
Hyperuricemia Associated With Rapid Renal Function Decline in Elderly Taiwanese Subjects
|
Yen C.-J.; Chiang C.-K.; Ho L.-C.; Hsu S.H.-J.; KUAN-YU HUNG; Wu K.-D.; Tsai T.-J. |
| 臺大學術典藏 |
2021-08-20T04:14:19Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Chen Y.-M.; KUAN-YU HUNG; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2021-08-20T04:14:19Z |
Life expectancy, expected years of life lost and survival of hemodialysis and peritoneal dialysis patients
|
Kao T.-W.; Huang J.-W.; KUAN-YU HUNG; Chang Y.-Y.; Chen P.-C.; Yen C.-J.; Chen Y.-M.; Chu T.-S.; Wu M.-S.; Tsai T.-J.; Wu K.-D.; Wang J.-D. |
| 臺大學術典藏 |
2021-08-20T04:14:16Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Huang J.-W.; Yen C.-J.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Lien Y.-C.; KUAN-YU HUNG; Tsai T.-J. |
| 臺大學術典藏 |
2021-08-20T04:14:14Z |
Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly
|
Cheng H.-T.; Huang J.-W.; Chiang C.-K.; Yen C.-J.; KUAN-YU HUNG; Wu K.-D. |
| 臺大學術典藏 |
2021-08-20T04:14:13Z |
Glycosylated Hemoglobin and Albumin-Corrected Fructosamine Are Good Indicators for Glycemic Control in Peritoneal Dialysis Patients
|
Lee S.-Y.; Chen Y.-C.; Tsai I.-C.; Yen C.-J.; Chueh S.-N.; Chuang H.-F.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; KUAN-YU HUNG; Huang J.-W. |
| 臺大學術典藏 |
2021-08-20T04:14:13Z |
Lean Body Mass Predicts Long-Term Survival in Chinese Patients on Peritoneal Dialysis
|
Huang J.-W.; Lien Y.-C.; Wu H.-Y.; Yen C.-J.; Pan C.-C.; Hung T.-W.; Su C.-T.; Chiang C.-K.; Cheng H.-T.; KUAN-YU HUNG |
| 臺大學術典藏 |
2021-08-20T04:14:13Z |
High peritoneal KT/V and peritonitis rates are associated with peritoneal calcification.
|
Huang J.W.; Lien Y.C.; Yang C.Y.; Liu K.L.; Fang C.C.; Wu C.K.; Lee J.K.; Wu H.Y.; Chiang C.K.; Cheng H.T.; Yen C.J.; KUAN-YU HUNG |
| 臺大學術典藏 |
2021-08-20T04:14:11Z |
Peritoneal dialysis peritonitis by anaerobic pathogens: A retrospective case series
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; Chen H.-W.; Fang C.-C.; Yen C.-J.; Chiang C.-K.; KUAN-YU HUNG; Huang J.-W. |
| 臺大學術典藏 |
2021-08-20T04:14:10Z |
Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis
|
Huang J.-W.; Lien Y.-C.; Yang C.-Y.; Liu K.-L.; Wu C.-F.; Yen C.-J.; Wu C.-K.; Lee J.-K.; Ho S.-R.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Shyu R.-S.; KUAN-YU HUNG |
| 臺大學術典藏 |
2021-08-20T04:14:10Z |
Citrobacter peritoneal dialysis peritonitis: Rare occurrence with poor outcomes
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; Chen H.-W.; Fang C.-C.; Yen C.-J.; Chiang C.-K.; KUAN-YU HUNG; Huang J.-W. |
| 臺大學術典藏 |
2021-08-20T04:14:08Z |
Serum vitamin D levels are positively associated with varicella zoster immunity in chronic dialysis patients
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; Yen C.-J.; Chiang C.-K.; Huang J.-W.; KUAN-YU HUNG |
| 臺大學術典藏 |
2021-08-20T04:14:07Z |
Acinetobacter peritoneal dialysis peritonitis: A changing landscape over time
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; Chen H.-W.; Fang C.-C.; Yen C.-J.; Chiang C.-K.; KUAN-YU HUNG; Huang J.-W. |
| 臺大學術典藏 |
2021-08-20T04:14:06Z |
Serum free 1,25-dihydroxy-vitamin D is more closely associated with fibroblast growth factor 23 than other vitamin D forms in chronic dialysis patients
|
Chao C.-T.; Lee S.-Y.; Yen C.-J.; Chiang C.-K.; Huang J.-W.; KUAN-YU HUNG |
| 臺大學術典藏 |
2021-08-20T04:14:06Z |
Viridans streptococci in peritoneal dialysis peritonitis: Clinical courses and long-term outcomes
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; Chen H.-W.; Fang C.-C.; Yen C.-J.; Chiang C.-K.; KUAN-YU HUNG; Huang J.-W. |
